4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists - Yuji Uehara; Shumei Kato; Daisuke Nishizaki; Hirotaka Miyashita; Suzanna Lee; Mary K. Nesline; Sarabjot Pabla; Jeffrey M. Conroy; Paul DePietro; Heidi Ko; Jason K. Sicklick; Razelle Kurzrock (Cancer Communications)